Overview

Low Versus High Dose Magnesium Sulfate in the Early Management of Rapid Atrial Fibrillation

Status:
Completed
Trial end date:
2014-08-01
Target enrollment:
Participant gender:
Summary
Objective: To assess the efficacy and the safety of high (9g) and low dose (4.5g) of MgS in the immediate treatment of rapid AF.
Phase:
Phase 3
Details
Lead Sponsor:
University of Monastir
Treatments:
Magnesium Sulfate